ReWalk Robotics inks soft exoskeleton research, licensing deal with Harvard

ReWalk Robotics (NSDQ:RWLK) has inked both a collaborative research and exclusive licensing agreement with Harvard Collage, looking to partner on research for the development of its soft-suit exoskeleton, according to a recently posted SEC filing.

Through the collaborative deal, both groups will join to aid in the development of soft-suit exoskeleton technologies designed to treat lower limb disabilities, the Marlborough, Mass.-based company said. The suit is intended to treat stroke, multiple sclerosis, mobility limitations for the elderly and other medical applications, ReWalk said.

The licensing agreement will grant ReWalk Robotics an exclusive, worldwide royalty-bearing license for certain patents related to the lightweight soft-suit exoskeleton technologies, according to an SEC filing.

The collaborative agreement was inked on May 1, while the licensing deal was signed on April 1, according to the filing.

Last week, ReWalk Robotics said it plans to expand the clinical study of its ReStore soft exo-suit device to five US research centers.

The post ReWalk Robotics inks soft exoskeleton research, licensing deal with Harvard appeared first on MassDevice.

from MassDevice https://ift.tt/2z3WQGm